Variceal sclerosing agents.
D000818:Animals; D004932:Esophageal and Gastric Varices / Q000628:therapy*; D006471:Gastrointestinal Hemorrhage / Q000628:therapy; D006801:Humans; D009829:Oleic Acids / Q000009:adverse effects / Q000627:therapeutic use; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000009:adverse effects / Q000627:therapeutic use; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D012976:Sodium Morrhuate / Q000009:adverse effects / Q000627:therapeutic use; D012981:Sodium Tetradecyl Sulfate / Q000009:adverse effects / Q000627:therapeutic use
D009829:Oleic Acids; D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols; D012976:Sodium Morrhuate; D012981:Sodium Tetradecyl Sulfate; C033343:ethanolamine oleate